2015

WuXi, PRA end China partnership

Friday, December 11, 2015

WuXi PharmaTech, an open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, and PRA Health Sciences, a global clinical CRO, have announced a restructuring of their relationship for the delivery of clinical trial management services in China, Macau and Hong Kong.

[Read More]

LabCorp acquires Pathology Inc assets

Friday, December 11, 2015

Laboratory Corporation of America Holdings (LabCorp), a Burlington, N.C.-based healthcare diagnostics company, has entered into a definitive agreement to acquire substantially all of the operating assets of Pathology Inc., including patient service centers, used to conduct Pathology’s medical testing and services business.

[Read More]

Treeway sees positive data results for ALS treatment

Thursday, December 10, 2015

Treeway, a biotech company developing therapies against amyotrophic lateral sclerosis (ALS), today announced the completion of two successful phase I trials with its lead compound TW001, a more patient-friendly oral formulation of the Japanese stroke and ALS therapy edaravone. [Read More]